Cytogenetic Analysis of the Results of Genome Editing on the Cell Model of Parkinson’s Disease
- Autores: Novosadova E.V.1, Manuilova E.S.1, Nenasheva V.V.1, Tarantul V.Z.1, Grivennikov I.A.1, Khaspekov L.G.2, Illarioshkin S.N.2, Vetchinova A.S.2, Simonova V.V.2
- 
							Afiliações: 
							- Institute of Molecular Genetics, Russian Academy of Sciences
- Research Center of Neurology
 
- Edição: Volume 165, Nº 3 (2018)
- Páginas: 378-381
- Seção: Genetics
- URL: https://journals.rcsi.science/0007-4888/article/view/240322
- DOI: https://doi.org/10.1007/s10517-018-4174-y
- ID: 240322
Citar
Resumo
We performed a cytogenetic analysis of the results of CRISPR/Cas9-correction of G2019S mutation in LRRK2 gene associated with Parkinson’s disease. Genome editing was performed on induced pluripotent stem cells derived from fibroblasts of a patient carrying this mutation. A mosaic variant of tetraploidy 92 XXYY/46,XY (24-43% cells from various clones) was found in neuronal precursors differentiated from the induced pluripotent stem cells after gene editing procedure. Solitary cases of translocations and chromosome breaks were observed. These data confirm the importance of the development of new approaches ensuring genome stability in CRISPR/Cas9-edited cultures.
Sobre autores
E. Novosadova
Institute of Molecular Genetics, Russian Academy of Sciences
														Email: snillario@gmail.com
				                					                																			                												                	Rússia, 							Moscow						
E. Manuilova
Institute of Molecular Genetics, Russian Academy of Sciences
														Email: snillario@gmail.com
				                					                																			                												                	Rússia, 							Moscow						
V. Nenasheva
Institute of Molecular Genetics, Russian Academy of Sciences
														Email: snillario@gmail.com
				                					                																			                												                	Rússia, 							Moscow						
V. Tarantul
Institute of Molecular Genetics, Russian Academy of Sciences
														Email: snillario@gmail.com
				                					                																			                												                	Rússia, 							Moscow						
I. Grivennikov
Institute of Molecular Genetics, Russian Academy of Sciences
														Email: snillario@gmail.com
				                					                																			                												                	Rússia, 							Moscow						
L. Khaspekov
Research Center of Neurology
														Email: snillario@gmail.com
				                					                																			                												                	Rússia, 							Moscow						
S. Illarioshkin
Research Center of Neurology
							Autor responsável pela correspondência
							Email: snillario@gmail.com
				                					                																			                												                	Rússia, 							Moscow						
A. Vetchinova
Research Center of Neurology
														Email: snillario@gmail.com
				                					                																			                												                	Rússia, 							Moscow						
V. Simonova
Research Center of Neurology
														Email: snillario@gmail.com
				                					                																			                												                	Rússia, 							Moscow						
Arquivos suplementares
 
				
			 
						 
						 
						 
						 
					 
				 
  
  
  
  
  Enviar artigo por via de e-mail
			Enviar artigo por via de e-mail  Acesso aberto
		                                Acesso aberto Acesso está concedido
						Acesso está concedido Somente assinantes
		                                		                                        Somente assinantes
		                                					